Atlas Trials

Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects

Clinical trial NCT05252546 · COMPLETED

Trial details

NCT number
NCT05252546
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HER2-positive Recurrent / Metastatic Breast Cancer
Start date
2022-03-08
Primary completion
2022-08-02
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.